Recruiting Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer NCT03412877 Conditions Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +48 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
